Literature DB >> 9049226

The predominance of hepatitis delta virus genotype I among chronically infected Italian patients.

G A Niro1, A Smedile, A Andriulli, M Rizzetto, J L Gerin, J L Casey.   

Abstract

The sera of 46 Italian patients with chronic hepatitis delta virus (HDV) infection were analyzed for HDV RNA by polymerase chain reaction (PCR) amplification. Genetic analysis of sequences amplified from two regions of the HDV genome indicated that all HDV RNA-positive patients (98%) were infected with HDV genotype I. In Italy, infection with this genotype appeared to be associated with a broad spectrum of chronic disease. No subtypes of HDV genotype I were identified, nor were genetic variations clearly associated with different disease patterns; however, clustering of some sequences suggested correlations with geography and transmission route. Italian HDV genotype I sequences were more diverse than those from east Asia and North America, suggesting that HDV genotype I was likely introduced to Italy earlier and/or from multiple sources as compared to those areas. All sequences analyzed were predicted to fold into the unbranched rod structure typical of HDV RNA. Within this structure, three conserved features were identified, including sequences around the RNA editing site and the polyadenylation signal site. We conclude that in Italy, where HDV infection has been endemic, the overwhelmingly predominant genotype of HDV is genotype I.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9049226     DOI: 10.1002/hep.510250339

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  21 in total

1.  Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2.

Authors:  Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  High prevalence and predominance of hepatitis delta virus genotype 1 infection in Cameroon.

Authors:  Yacouba Foupouapouognigni; Dominique Noah Noah; Michèle Tagni Sartre; Richard Njouom
Journal:  J Clin Microbiol       Date:  2011-01-05       Impact factor: 5.948

3.  Alpha interferon and ribavirin combination therapy of chronic hepatitis D.

Authors:  Sabahattin Kaymakoglu; Cetin Karaca; Kadir Demir; Sule Poturoglu; Ahmet Danalioglu; Selim Badur; Murvet Bozaci; Fatih Besisik; Yilmaz Cakaloglu; Atilla Okten
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

4.  Molecular phylogenetic analysis of Iranian HDV complete genome.

Authors:  Farida Behzadian; Farzaneh Sabahi; Mohsen Karimi; Majid Sadeghizadeh; Nader Maghsoudi; Ramin Sarrami Forooshani; Leila Shahinsaz
Journal:  Virus Genes       Date:  2005-05       Impact factor: 2.332

5.  The fraction of RNA that folds into the correct branched secondary structure determines hepatitis delta virus type 3 RNA editing levels.

Authors:  Sarah D Linnstaedt; Wojciech K Kasprzak; Bruce A Shapiro; John L Casey
Journal:  RNA       Date:  2009-04-21       Impact factor: 4.942

6.  Clevudine inhibits hepatitis delta virus viremia: a pilot study of chronically infected woodchucks.

Authors:  John Casey; Paul J Cote; Illia A Toshkov; Chung K Chu; John L Gerin; William E Hornbuckle; Bud C Tennant; Brent E Korba
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

7.  Genetic changes in hepatitis delta virus from acutely and chronically infected woodchucks.

Authors:  John L Casey; Bud C Tennant; John L Gerin
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

8.  Effects of conserved RNA secondary structures on hepatitis delta virus genotype I RNA editing, replication, and virus production.

Authors:  Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  RNA editing in hepatitis delta virus genotype III requires a branched double-hairpin RNA structure.

Authors:  John L Casey
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Clinical presentation and genotype of hepatitis delta in Karachi.

Authors:  Tariq Moatter; Zaigham Abbas; Sabhita Shabir; Wasim Jafri
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.